Sigma-Aldrich Corporation Logo

Print Print page   Email Email page   PDF Download PDF    Add to Briefcase Add to Briefcase
« Previous Release | Next Release »

Sigma-Aldrich and Proteome Systems Announce Proteomics Alliance

ST. LOUIS--(BW HealthWire)--Oct. 25, 2000--Sigma-Aldrich (NASDAQ:SIAL), a $1 billion plus life science and high technology company announced its intention to enter into a manufacturing and exclusive distribution agreement with a leading proteomics company, Proteome Systems. Under the agreement, Sigma-Aldrich will exclusively manufacture and distribute certain products developed by Proteome Systems for use in proteomic analysis.

This alliance foreshadows a long-term relationship between Sigma-Aldrich and Proteome Systems with respect to the collaborative development of other proprietary Proteome Systems' technologies and systems for use in proteomic research.

Dave Julien, President of the Life Science Division of Sigma-Aldrich said, "As a leading supplier of life science products, our goal is to bring enabling technologies to our customers as quickly as possible. As part of our strategy to increase collaborations, we are pleased to announce this relationship with Proteome Systems. We believe Proteome Systems is a genuine leader in the field of proteomics and are excited about the opportunity to work with them on the definition and delivery of a complete solution for proteomics research."

CEO and founder of Proteome Systems, Dr. Keith Williams said, "We are delighted to have the opportunity to work together with one of the world's most experienced life sciences companies to open up the proteomics market globally. There is intense interest in proteomics but few have a clear understanding of how to translate the opportunities into products that will drive discovery. We are confident that a Proteome Systems/Sigma-Aldrich partnership has all of the ingredients required to design, develop and distribute key enabling technologies for proteomics."

About Proteome Systems

Proteome Systems is a proteomics company that is developing one of the world's most powerful proteomics platforms. With over 50 employees in Sydney and Boston, Proteome Systems is one of a small group of companies globally with the capacity to conduct large-scale proteomics. Proteome Systems is a leading innovator in the development of proteomics instrumentation and consumables. It is also pioneering bioinformatic aspects of proteomics. Proteome Systems has strategic technology alliances with Shimadzu Corporation of Japan and their mass spectrometry group Kratos Analytical (Manchester, UK), MicroFab Technologies (Plano, Texas USA), Gradipore (ASX Code: GDP; Sydney, Australia) and Geneva Bioinformatics (Geneva, Switzerland). Proteome Systems announced recently the opening of a 21,000 square feet proteomics factory in Woburn, Massachusetts to mirror its Sydney operations.

About Sigma-Aldrich

Sigma-Aldrich develops, manufactures and distributes the broadest range of high-quality biochemicals, organic chemicals, chromatography products and diagnostic reagents available in the world. The Company's products are used in high-tech research and development in universities and industry, in the diagnosis of disease, and as specialty chemicals for pharmaceutical and other manufacturing purposes in more than 160 countries. Sigma-Aldrich is committed to the success of its customers, employees and shareholders through life science, technology and service. For more information about Sigma-Aldrich, please visit its award winning Web site at


Close window | Back to top

CONTACT: Sigma-Aldrich
Russell Odegard, 314/286-6697
Proteome Systems
Keith Williams, 612/9889-1830